BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Breast Cancer
NCI Information
Our Treatment Approach
Clinical Trials
Support Groups
Effects of Treatment
Assess Your Risk
Patient Stories
Podcasts
Videos
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
P2C 9170
Principal Investigator:
Ma, Cynthia
Title:
A Phase II Trial of Neoadjuvant MK-2206 in Combination with either Anastrozole if Postmenopausal or Anastrozole and Goserelin if Premenopausal in Women with Clinical Stage 2 or 3 PIK3CA Mutant Estrogen Receptor Positive and HER2 Negative Invasive Breast Cancer
Phase:
II
Disease Site:
Breast, Female
Participating Site(s):
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this research study is to find out what effects, good and/or bad, the drug MK-2206 in combination with anastrozole with or without goserelin (depending on menopausal status) has on patients and their breast cancer.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)